- Report
- December 2025
- 241 Pages
Global
From €1620EUR$1,850USD£1,406GBP
- Report
- January 2026
- 192 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- February 2026
- 214 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- September 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- September 2025
- 210 Pages
Global
From €4375EUR$4,995USD£3,797GBP
- Report
- July 2025
- 100 Pages
United States
From €3459EUR$3,950USD£3,003GBP
- Report
- August 2025
- 199 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 185 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- February 2026
- 541 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- June 2018
- 315 Pages
Global
From €3064EUR$3,499USD£2,660GBP
- Report
- February 2025
- 386 Pages
Global
From €4335EUR$4,950USD£3,763GBP
- Report
- November 2024
- 100 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- January 2024
- 200 Pages
Global
From €3635EUR$4,150USD£3,155GBP
- Report
- January 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- June 2024
- 140 Pages
Europe
From €3389EUR$3,869USD£2,941GBP
- Report
- June 2024
- 140 Pages
Latin America
From €3389EUR$3,869USD£2,941GBP
- Report
- June 2024
- 140 Pages
Asia Pacific
From €3389EUR$3,869USD£2,941GBP
- Report
- June 2024
- 140 Pages
Middle East, Africa
From €3389EUR$3,869USD£2,941GBP
- Report
- April 2024
- 140 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- December 2024
- 184 Pages
Africa, Middle East
From €1314EUR$1,500USD£1,140GBP

The Biosimulation market is a subset of the biotechnology industry that focuses on the development of computer-based models to simulate biological processes. These models are used to study the behavior of biological systems, such as the interactions between cells, organs, and organisms. Biosimulation can be used to predict the effects of drugs, understand the mechanisms of disease, and develop new treatments. It can also be used to optimize the production of biopharmaceuticals and to design new bioprocesses.
Biosimulation is a rapidly growing field, with many companies investing in the development of new technologies and applications. Companies in the market include Certara, Entelos, Simulations Plus, Schrodinger, and In Silico Biosciences. Show Less Read more